McClellan Outlines Vision For Device User Fees, Third-Party Inspections

Incoming FDA commissioner Mark McClellan, MD/PhD, is pledging to hold the agency to premarket review performance goals mandated under the "Medical Device User Fee and Modernization Act" if the bill becomes law

More from Archive

More from Medtech Insight